期刊文献+

乳杆菌活菌胶囊联合保妇康栓治疗老年性阴道炎的疗效观察 被引量:6

Living Preparation of Lactobacillus in Combination of Baofukang Suppository for Senile Vaginitis
下载PDF
导出
摘要 目的:观察乳杆菌活菌胶囊(定君生)联合保妇康栓治疗老年性阴道炎的疗效。方法:观察组104例老年性阴道炎患者使用保妇康栓1周后加用乳杆菌活菌胶囊治疗10天;对照组96例老年性阴道炎患者则单纯应用保妇康栓1周。两组均在停药后3~7d复查比较其治愈率、总有效率。两组治愈者均在停药90d复查,比较其复发率。结果:观察组治愈率为73.08%,总有效率为96.15%;对照组治愈率为63.54%,总有效率为91.67%,两组差异无统计学意义(P>0.05)。观察组复发率为0,对照组复发率为21.88%,两组差异有统计学意义(P<0.05)。结论:乳杆菌活菌胶囊联合保妇康栓治疗老年性阴道炎疗效显著,复发率低,值得临床推广。 OBJECTIVE:To evaluate the clinical efficacy of Living Preparation of Lactobacillus combined Baofukang Suppository for senile vaginitis.METHODS:104 senile vaginitis cases(observation group) were assigned to receive add-on Living Preparation of Lactobacillus for 10 days after 1-week treatment with Baofukang Suppository,and another 96 cases to receive Baofukang Suppository alone for 1 week.The cure rates and the total effective rates were compared between the two groups after drug withdrawal for 3 to 7 days,and the recurrence rates were compared after drug withdrawal for 90 days.RESULTS:There were no significant differences between the observation group and the control group with respect to the cure rate(73.08% vs.63.54%) and the total effective rate(96.15% vs.91.67%)(P 〉 0.05).However,there were significant differences between the two groups in the recurrence rate(0% vs.21.88%)(P 〈 0.05).CONCLUSION:Treatment of senile vaginitis with Living Preparation of Lactobacillus combined Baofukang Suppository is more effective with lower recurrence rate compared with Baofukang Suppository alone,hence the combination therapy is worthy of being recommended in clinical practice.
作者 曾玲
出处 《中国医院用药评价与分析》 2010年第10期933-934,共2页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 老年性阴道炎 乳杆菌活菌胶囊 保妇康栓 复发率 Senile vaginitis Living Preparation of Lactobacillus Baofukang Suppository Recurrence rate
  • 相关文献

参考文献7

二级参考文献29

  • 1董德刚,常德安,李芳,孙文平,康白.乳杆菌制剂对非特异性阴道炎的治疗及其机制的研究[J].中国微生态学杂志,1994,6(2):14-18. 被引量:17
  • 2贾忠伟,吕晓玲,董振香.定君生[J].中国新药杂志,2005,14(12):1489-1490. 被引量:22
  • 3Pabich WL,Fihn SD,Stamm WE,et al.Prevalence and determinants of vaginal flora alterations in postmenopausal women[J].J Infect Dis,2003,188(7):1054-1058
  • 4Gregor Reid.Probiotic agents to protect the urogenital tract against infection[J].Clin Nutri,2001,73(2):437-443
  • 5Swygard H, Sena AC, Hobbs MM, et al. Trichomoniasis: clinical manifestations, diagnosis and management. Sex Transm Infect,2004,80(2) :91-95.
  • 6Riggs MA, Klebanoff MA. Treatment of vaginal infections to prevent preterm birth : a meta-analysis. Clin Obstet Gynecol, 2004,47 ( 4 ) :796-807.
  • 7Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazoleresistant vaginal trichomoniasis. Clin Infect Dis,2001,33 (8) :1341-1346.
  • 8Kigozi GG,Brahmbhatt H,Wabwire-Mangen F,et al.Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy:a subanalysis of a randomized trial in Rakai,Uganda.Am J Obstet Gynecol,2003,189(5):1398-1400.
  • 9Bachmann GA,Nevadunsky NS.Diagnosis and treatment of atrophic vaginitis.Am Fam Physician,2000,61(10):3090-3096.
  • 10Shapiro RA,Schubert CJ,Siegel RM.Neisseria gonorrhea infections in girls younger than 12 years of age evaluated for vaginitis.Pediatrics,1999,104(6):e72.

共引文献385

同被引文献28

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部